tiprankstipranks
Ensysce focused on clinical development milestones for PF614, PF614-MPAR
PremiumThe FlyEnsysce focused on clinical development milestones for PF614, PF614-MPAR
3M ago
Ensysce Biosciences regains compliance with Nasdaq
Premium
The Fly
Ensysce Biosciences regains compliance with Nasdaq
3M ago
Ensysce Biosciences trading resumes
Premium
The Fly
Ensysce Biosciences trading resumes
3M ago
Ensysce Biosciences Reports Improved Financial Results
PremiumCompany AnnouncementsEnsysce Biosciences Reports Improved Financial Results
5M ago
Is ENSC a Buy, Before Earnings?
Premium
Pre-Earnings
Is ENSC a Buy, Before Earnings?
5M ago
Ensysce Biosciences receives extension to demonstrate Nasdaq compliance
Premium
The Fly
Ensysce Biosciences receives extension to demonstrate Nasdaq compliance
5M ago
Ensysce Biosciences receives Nasdaq notice
PremiumThe FlyEnsysce Biosciences receives Nasdaq notice
6M ago
Ensysce Biosciences to present at upcoming meetings
Premium
The Fly
Ensysce Biosciences to present at upcoming meetings
6M ago
Ensysce Biosciences submits Phase 3 protocol to FDA
Premium
The Fly
Ensysce Biosciences submits Phase 3 protocol to FDA
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100